|This past year Vasalgel has had fantastic media attention - from Medical Daily, ABC TV, and Smithsonian to US News & World Report, Vice and Priceonomics. We've heard from many people who are thrilled to learn about this revolution in male contraception and want to help get it to clinical trials! We have also begun talking to investors who are supportive of Vasalgel's social mission to provide the contraceptive around the globe at an affordable price.
The Vasalgel project recently received a $37,000 grant from an anonymous donor; $13,000 from a Woodside, California foundation; $2,000 from a family donor-advised fund; and a repeat $5,000 donation from a longtime follower in Seattle-- not to mention the countless smaller donations that keep things moving. We're thankful that so many people support the development work on Vasalgel. Contributions from men and women who want more options for male contraception and gifts from foundations allowed us to make significant progress this year.
Please consider a year-end gift to Parsemus Foundation to help prepare for next year's first clinical trial.